Stock listing
Alkermes Plc
- Ticker
- Lang & Schwarz: A1JKVH
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Alkermes Plc
The company focuses on developing innovative medicines for patients with serious mental health conditions and addiction. Alkermes is committed to improving patient outcomes through its research and development efforts.
Latest news from Alkermes Plc
Alkermes Announces Positive Phase 1b Results Demonstrating Clinical Proof-of-Concept for ALKS 7290 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Sep 21, 2026
Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors
Sep 16, 2026
Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program
Sep 10, 2026
The Lancet Neurology Publishes Data From Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 1
Aug 24, 2026